Profil
Richard Schwartz worked as Senior Director-Processing & Manufacturing Science at MedImmune Vaccines, Inc. from 2005 to 2008.
He then worked as Chief-Vaccine Production Program at Vaccine Research Center.
Later, he worked as Senior Vice President-Process Development at Synlogic, Inc. and as Senior Vice President-Technical Operations at Vaxart, Inc. In 2018-2019, he was Head-Technical Operations at CRISPR Therapeutics AG.
Dr. Schwartz received his undergraduate, graduate, and doctorate degrees from the University of Michigan.
Tidigare kända positioner av Richard Schwartz
| Företag | Position | Slut |
|---|---|---|
| CRISPR THERAPEUTICS AG | Teknisk/Vetenskaplig/F&U Direktör | 2019-10-01 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Företagsledare/Principal | 2008-05-01 |
Vaccine Research Center | Företagsledare/Principal | - |
| VAXART, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
| SYNLOGIC, INC. | Företagsledare/Principal | - |
Richard Schwartzs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaccine Research Center | |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Synlogic, Inc.
Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Vaxart, Inc.
Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
















